Use of plasmid-derived external quality control samples in pharmacogenetic testing

Pharmacogenomics

Volumn 9, Issue 9, 2008, Pages 1261-1266

  van der Straaten, Tahar ^a   Swen, Jesse ^a   Baak Pablo, Renee ^a   Guchelaar, Henk Jan ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Genotyping; Pharmacogenetics; Pyrosequencing; Quality controls

Indexed keywords

ARTICLE; DRUG RESEARCH; GENE FREQUENCY; GENE SEQUENCE; GENETIC SCREENING; GENOMICS; GENOTYPE; MEDICAL LITERATURE; PATIENT CARE; PHARMACEUTICAL CARE; PHARMACOGENETICS; PLASMID; PUBLICATION; QUALITY CONTROL; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; BASE SEQUENCE; GENETIC SCREENING; HUMANS; MOLECULAR SEQUENCE DATA; PHARMACEUTICAL PREPARATIONS; PHARMACOGENETICS; PLASMIDS; QUALITY CONTROL;

EID: 55449111677     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/14622416.9.9.1261     Document Type: Article

References (9)

1. Wolf CR, Smith G, Smith RL: Science, medicine, and the future: pharmacogenetics. BMJ 320, 987-990 (2000).
2. Evans WE, Relling MV: Moving towards individualized medicine with pharmacogenomics. Nature 429, 464-468 (2004).
3. Swen JJ, Huizinga TW, Gelderblom, H et al.: Translating pharmacogenomics: challenges on the road to the clinic. PLoS Med. 4, E209 (2007).
4. Gage BF, Lesko LJ: Pharmacogenetics of warfarin: regulatory, scientific, and clinical issues. J. Thromb. Thrombolysis 25, 45-51 (2008).
5. Mallal S, Phillips E, Carosi G et al.: HLA-B*5701 screening for hypersensitivity to abacavir. N. Engl. J. Med. 358, 568-579 (2008).
6. Williams LO, Cole EC, Lubin IM, Iglesias NI, Jordan RL, Elliott LE: Quality assurance in human molecular genetics testing: status and recommendations. Arch. Pathol. Lab. Med. 127, 1353-1358 (2003).
7. Chen B, O'Connell CD, Boone DJ et al.: Developing a sustainable process to provide quality control materials for genetic testing. Genet. Med. 7, 534-549 (2005).
8. Jarvis M, Iyer RK, Williams LO et al.: A novel method for creating artificial mutant samples for performance evaluation and quality control in clinical molecular genetics. J. Mol. Diagn. 7, 247-251 (2005).
9. Wessels JA, de Vries-Bouwstra JK, Heijmans BT et al.: Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes. Arthritis Rheum. 54, 1087-1095 (2006).